Cochrane Abstracts
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Prognostic Value of Test(s) for O6‐methylguanine–DNA Methyltransferase (MGMT) Promoter Methylation for Predicting Overall Survival in People With Glioblastoma Treated With Temozolomide." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Prognostic_value_of_test_s__for_O6‐methylguanine_DNA_methyltransferase__MGMT__promoter_methylation_for_predicting_overall_survival_in_people_with_glioblastoma_treated_with_temozolomide_New. Accessed 09 June 2023.
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Prognostic_value_of_test_s__for_O6‐methylguanine_DNA_methyltransferase__MGMT__promoter_methylation_for_predicting_overall_survival_in_people_with_glioblastoma_treated_with_temozolomide_New. Accessed June 9, 2023.
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Prognostic_value_of_test_s__for_O6‐methylguanine_DNA_methyltransferase__MGMT__promoter_methylation_for_predicting_overall_survival_in_people_with_glioblastoma_treated_with_temozolomide_New
Prognostic Value of Test(s) for O6‐methylguanine–DNA Methyltransferase (MGMT) Promoter Methylation for Predicting Overall Survival in People With Glioblastoma Treated With Temozolomide [Internet]. In: Cochrane Abstracts. [cited 2023 June 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Prognostic_value_of_test_s__for_O6‐methylguanine_DNA_methyltransferase__MGMT__promoter_methylation_for_predicting_overall_survival_in_people_with_glioblastoma_treated_with_temozolomide_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
ID - 431926
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Prognostic_value_of_test_s__for_O6‐methylguanine_DNA_methyltransferase__MGMT__promoter_methylation_for_predicting_overall_survival_in_people_with_glioblastoma_treated_with_temozolomide_New
DB - Evidence Central
DP - Unbound Medicine
ER -
